| Procedure Code | Description | Setting | Coverage |
|---|---|---|---|
| 87627 | INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); JOINT SPACE PATHOGENS AND DRUG RESISTANCE GENES, MULTIPLEX AMPLIFIED PROBE TECHNIQUE, 26 OR MORE TARGETS | outpatient | covered |
| 87999 | UNLISTED MICROBIOLOGY PROCEDURE | outpatient | covered |
| A2023 | INNOVAMATRIX PD, 1 MG | outpatient | noncovered |
| A2035 | CORPLEX P OR THERACOR P OR ALLACOR P, PER MILLIGRAM | outpatient | noncovered |
| A4100 | NON-SHEET FORM SKIN SUBSTITUTE, FDA CLEARED AS A DEVICE, NOT OTHERWISE SPECIFIED (LIST IN ADDITION TO PRIMARY PROCEDURE) | outpatient | noncovered |
| Q4139 | AMNIOMATRIX OR BIODMATRIX, INJECTABLE, 1 CC | outpatient | noncovered |
| Q4145 | EPIFIX, INJECTABLE, 1 MG | outpatient | noncovered |
| Q4155 | NEOXFLO OR CLARIXFLO, 1 MG | outpatient | noncovered |
Showing 5 of 31 procedures. Sign up free for a 7-day unlimited trial.
Create free account